Related Experiment Videos
Drug-induced lung injury
Jeremy J Erasmus1, H Page McAdams, Santiago E Rossi
1Department of Radiology, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Seminars in Roentgenology
|May 4, 2002
Summary
Prompt diagnosis of drug-induced lung injury (DILI) is crucial for patient outcomes. Early recognition and cessation of offending medications can lead to regression of lung damage.
Area of Science:
- Pulmonology
- Pharmacology
- Pathology
Background:
- Drug-induced lung injury (DILI) is a significant cause of morbidity and mortality.
- Diagnosis is challenging due to overlapping clinical and radiological features with other lung diseases.
- Limited histopathologic responses in the lungs complicate diagnosis.
Purpose of the Study:
- To highlight the importance of prompt diagnosis of DILI.
- To emphasize the need for a high index of suspicion in diagnosing DILI.
- To correlate histopathologic patterns and radiologic findings with DILI.
Main Methods:
- Review of clinical, radiological, and histopathological manifestations of DILI.
- Analysis of drugs commonly associated with lung injury.
- Differential diagnosis considerations including infection, radiation pneumonitis, and disease recurrence.
Main Results:
- Early DILI often shows regression upon drug cessation.
- Recognizing limited histopathologic patterns (e.g., diffuse alveolar damage, NSIP, BOOP, EP, hemorrhage) aids diagnosis.
- Knowledge of commonly implicated drugs facilitates identification.
Conclusions:
- A high index of suspicion is essential for diagnosing DILI.
- Understanding characteristic lung injury patterns and associated drugs improves diagnostic accuracy.
- Timely diagnosis and intervention can prevent severe outcomes.